Literature DB >> 2427127

Circularization of retroviral genomic RNA and the control of RNA translation, packaging and reverse transcription.

J L Darlix.   

Abstract

Translation, packaging and reverse transcription of the genomic RNA of retroviruses appear to be regulated by short and long range RNA-RNA interactions which take place within the 5'-600 nt and between the 5' and 3' untranslated sequences. The 5' (R and U5) and 3' (Dr and U3) domains of the genomic RNA together with the nucleic acid binding protein (NBP) would control the balance between the open state of the viral genomic RNA, correlated with an efficient RNA translation and the closed state, with the circular viral RNA efficiently packaged into virions. Retroviral NBP might well drive the packaging of the viral RNA as well as improve reverse transcription of the circular virion RNA.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2427127     DOI: 10.1016/s0300-9084(86)81057-4

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  4 in total

1.  Circularization of the HIV-1 genome facilitates strand transfer during reverse transcription.

Authors:  Nancy Beerens; Jørgen Kjems
Journal:  RNA       Date:  2010-04-29       Impact factor: 4.942

2.  Generation of a helper cell line for packaging avian leukosis virus-based vectors.

Authors:  P Savatier; C Bagnis; P Thoraval; D Poncet; M Belakebi; F Mallet; C Legras; F L Cosset; J L Thomas; Y Chebloune
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

3.  Transduction of the cellular src gene and 3' adjacent sequences in avian sarcoma virus PR2257.

Authors:  J Geryk; P Dezélée; J V Barnier; J Svoboda; J Nehyba; I Karakoz; A V Rynditch; B A Yatsula; G Calothy
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

4.  Small finger protein of avian and murine retroviruses has nucleic acid annealing activity and positions the replication primer tRNA onto genomic RNA.

Authors:  A C Prats; L Sarih; C Gabus; S Litvak; G Keith; J L Darlix
Journal:  EMBO J       Date:  1988-06       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.